Advances in the management of colonic diverticulitis

CMAJ. Canadian Medical Association Journal

Volumn 184, Issue 13, 2012, Pages 1470-1476

  Tursi, Antonio ^a  

^a Azienda Sanitaria Locale Barletta Andria Trani ASL BAT   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BALSALAZIDE; CIPROFLOXACIN; MESALAZINE; METRONIDAZOLE; MMX; MORPHINE; NARCOTIC ANALGESIC AGENT; PETHIDINE; PLACEBO; PROBIOTIC AGENT; RIFAXIMIN; SULTAMICILLIN; UNCLASSIFIED DRUG;

ABDOMINAL PAIN; ACUTE DISEASE; ANTIBIOTIC THERAPY; COLON DIVERTICULOSIS; COLONOSCOPY; COMORBIDITY; COMPUTER ASSISTED TOMOGRAPHY; CONSTIPATION; DIARRHEA; DISEASE SEVERITY; DRUG EFFICACY; ELECTIVE SURGERY; FEVER; HIGH FIBER DIET; HUMAN; IRRITABLE COLON; LAPAROSCOPY; LAPAROTOMY; OUTPATIENT CARE; PAIN; PATHOGENESIS; PATHOPHYSIOLOGY; PERITONITIS; PRACTICE GUIDELINE; RECURRENT DISEASE; REVIEW; SENSITIVITY AND SPECIFICITY;

EID: 84866531904     PISSN: 08203946     EISSN: 14882329     Source Type: Journal    
DOI: 10.1503/cmaj.120580     Document Type: Review

References (51)

1. Weizman AV, Nguyen GC. Diverticular disease: epidemiology and management. Can J Gastroenterol 2011;25:385-9.
2. Tursi A, Papagrigoriadis S. Review article: the current and evolving treatment of colonic diverticular disease. Aliment Pharmacol Ther 2009;30:532-46.
3. Shahedi K, Fuller G, Bolus R, et al. Progression from incidental diverticulosis to acute diverticulitis [abstract]. Gastroenterology 2012;142(Suppl 1):144.
4. Etzioni DA, Mack TM, Beart RW Jr, et al. Diverticulitis in the United States: 1998-2005: changing patterns of disease and treatment. Ann Surg 2009;249:210-7.
5. Jung HK, Choung RS, Locke GR III, et al. Diarrhea-predominant irritable bowel syndrome is associated with diverticular disease: a population-based study. Am J Gastroenterol 2010;105:652-61.
6. Ambrosetti P. Acute diverticulitis of the left colon: value of the initial CT and timing of elective colectomy. J Gastrointest Surg 2008;12:1318-20.
7. van Randen A, Laméris W, van Es HW, et al.; OPTIMA Study Group. A comparison of the accuracy of ultrasound and computed tomography in common diagnoses causing acute abdominal pain. Eur Radiol 2011;21:1535-45.
8. Ghorai S, Ulbright TM, Rex DK. Endoscopic findings of diverticular inflammation in colonoscopy patients without clinical acute diverticulitis: prevalence and endoscopic spectrum. Am J Gastroenterol 2003;98:802-6. (Pubitemid 36576305)
9. Tursi A, Elisei W, Giorgetti GM, et al. Inflammatory manifestations at colonoscopy in patients with colonic diverticular disease. Aliment Pharmacol Ther 2011;33:358-65.
10. Tursi A. Diverticular disease: a therapeutic overview. World J Gastrointest Pharmacol Ther 2010;1:27-35.
11. Lahat A, Yanai H, Menachem Y, et al. The feasibility and risk of early colonoscopy in acute diverticulitis: a prospective controlled study. Endoscopy 2007;39:521-4. (Pubitemid 46971578)
12. Rafferty J, Shellito P, Hyman NH, et al. Practice parameters for sigmoid diverticulitis. Dis Colon Rectum 2006;49:939-44. (Pubitemid 44060847)
13. Schechter S, Mulvey J, Eisenstat TE. Management of uncomplicated acute diverticulitis: results of a survey. Dis Colon Rectum 1999;42:470-5.
14. World Gastroenterology Organisation Practice Guidelines: Diverticular disease. Milwaukee (WI): World Gastroenterology Organisation; 2007. Available: www. worldgastroenterology.org/assets /downloads /en/pdf/guidelines/07- diverticular-disease.pdf (accessed 2012 July 19).
15. Stollman NH, Raskin JB. Diagnosis and management of diverticular disease of the colon in adults. Ad Hoc Practice Parameters Committee of the American College of Gastroenterology. Am J Gastroenterol 1999;94:3110-21.
16. Broderick-Villa G, Burchette RJ, Collins JC, et al. I. Hospitalization for acute diverticulitis does not mandate routine elective colectomy. Arch Surg 2005;140:576-81.
17. Anaya DA, Flum DR. Risk of emergency colectomy and colostomy in patients with diverticular disease. Arch Surg 2005;140:681-5. (Pubitemid 41124006)
18. Binda GA, Arezzo A, Serventi A, et al. Italian Study Group on Complicated Diverticulosis (GISDIC). Multicentre observational study of the natural history of left-sided acute diverticulitis. [published erratum appears in Br J Surg 2012;99:600]. Br J Surg 2012;99:276-85.
19. Crowe FL, Appleby PN, Allen NE, et al. Diet and risk of diverticular disease in Oxford cohort of European Prospective Investigation into Cancer and Nutrition (EPIC): prospective study of British vegetarians and non-vegetarians. BMJ 2011;343:d4131.
20. Peery AF, Barrett PR, Park D, et al. Sandler RS. A high-fiber diet does not protect against asymptomatic diverticulosis. Gastroenterology 2012;142:266-72.
21. Unlü C, Daniels L, Vrouenraets BC, et al. A systematic review of high-fibre dietary therapy in diverticular disease. Int J Colorectal Dis 2012;27:419-27.
22. Strate LL, Liu YL, Syngal S, et al. Nut, corn, and popcorn consumption and the incidence of diverticular disease. JAMA 2008;300:907-14.
23. Tursi A. Colonic microflora imbalance and diverticular disease. Dig Liver Dis 2010;42:458.
24. Bianchi M, Festa V, Moretti A, et al. Meta-analysis: long-term therapy with rifaximin in the management of uncomplicated diverticular disease. Aliment Pharmacol Ther 2011;33:902-10.
25. Zullo A, Hassan C, Maconi G, et al. Cyclic antibiotic therapy for diverticular disease: a critical reappraisal. J Gastrointestin Liver Dis 2010;19:295-302.
26. Maconi G, Barbara G, Bosetti C, et al. Treatment of diverticular disease of the colon and prevention of acute diverticulitis: a systematic review. Dis Colon Rectum 2011;54:1-1326-38.
27. Scarpignato C, Pelosini I. Experimental and clinical pharmacology of rifaximin, a gastrointestinal selective antibiotic. Digestion 2006;73(Suppl 1):13-27.
28. Stocchi L. Current indications and role of surgery in the management of sigmoid diverticulitis. World J Gastroenterol 2010;16:804-17.
29. Egger B, Peter MK, Candinas D. Persistent symptoms after elective sigmoid resection for diverticulitis. Dis Colon Rectum 2008; 51:1044-8.
30. Narayan R, Floch MH. Microscopic colitis as part of the natural history of diverticular disease. Am J Gastroenterol 2002;97(1 Suppl):S112-13.
31. Cianci R, Iacopini F, Petruzziello L, et al. Involvement of central immunity in uncomplicated diverticular disease. Scand J Gastroenterol 2009;44:108-15.
32. Elli L, Roncoroni L, Bardella MT, et al. Absence of mucosal inflammation in uncomplicated diverticular disease. Dig Dis Sci 2011; 56:2098-103.
33. Tursi A, Brandimarte G, Elisei W, et al. Assessment and grading of mucosal inflammation in colonic diverticular disease. J Clin Gastroenterol 2008;42:699-703.
34. Tursi A, Brandimarte G, Elisei W, et al. Faecal calprotectin in colonic diverticular disease: a case-control study. Int J Colorectal Dis 2009;24:49-55.
35. Simpson J, Sundler F, Humes DJ, et al. Post inflammatory damage to the enteric nervous system in diverticular disease and its relationship to symptoms. Neurogastroenterol Motil 2009;21:847-58.
36. Tursi A, Elisei W, Brandimarte G, et al. Musosal tumour necrosis factor-alpha in diverticular disease of the colon is overexpressed with disease severity. Colorectal Dis 2012;14:e258-63.
37. Humes DJ, Simpson J, Smith J, et al. Visceral hypersensitivity in symptomatic diverticular disease and the role of neuropeptides and low grade inflammation. Neurogastroenterol Motil 2012;24:318-e163.
38. Tursi A, Elisei W, Giorgetti GM, et al. Persistence of endoscopic and histological inflammation are risk factors of diverticulitis recurrence after attack of acute uncomplicated diverticulitis [abstract]. Gastroenterology 2011;140(Suppl 1):S-61.
39. Tursi A, Joseph RE, Streck P. Expanding applications: the potential usage of 5-aminosalicylic acid in diverticular disease. Dig Dis Sci 2011;56:3112-21.
40. Kruis W, Meier E, Schumacher M, et al. Treatment of painful diverticular disease of the colon with mesalamine: a placebo-controlled study [abstract]. Gastroenterology 2007;132:A-191.
41. Tursi A, Brandimarte G, Daffinà R. Long-term treatment with mesalazine and rifaximin versus rifaximin alone for patients with recurrent attacks of acute diverticulitis of colon. Dig Liver Dis 2002;34:510-5. (Pubitemid 34830693)
42. Tursi A, Brandimarte G, Giorgetti GM, et al. Balsalazide and/or high-potency probiotic mixture (VSL#3) in maintaining remission after attack of acute, uncomplicated diverticulitis of the colon. Int J Colorectal Dis 2007;22:1103-8. (Pubitemid 47500254)
43. Stollman N, Magowan S, Shanahn F, et al. Efficacy of delayed-release mesalamine in the prevention of GI symptoms following acute diverticulitis: results of the DIVA trial. Am J Gastroenterol 2010;105(Suppl 1):139.
44. Parente F, Bargiggia S, Prada A, et al. Randomised multicentre pilot double-blind placebo-controlled study evaluating the efficacy and safety of mesalazine in the prevention of recurrence of diverticulitis: interim analysis after 24-month follow-up. Dig Liver Dis 2011;43(Suppl 1):135
45. Gaman A. Teodorescu R, Georhescu EF, Abagiu MT. Prophylactic effects of mesalamine in diverticular disease [abstract]. Falk Symposium 2011;178: 13.
46. ClinicalTrials.gov. A Phase III, randomised, double-blind, dose-response, stratified, placebo-controlled study evaluating the safety and efficacy of SPD476 versus placebo over 104 weeks in the prevention of recurrence of diverticulitis. (NCT00545103). Available: www.clinicaltrials.gov/ct2/show/ NCT00545103 (accessed 2012 July 19).
47. ClinicalTrials.gov. A phase III, randomised, double-blind, dose-response, stratified, placebo-controlled study evaluating the safety and efficacy of SPD476 versus placebo over 104 weeks in the prevention of recurrence of diverticulitis (NCT00545740). Available: www.clinicaltrials.gov/ct2/show/ NCT00545740 (accessed 2012 July 19).
48. Yan F, Polk DB. Probiotics and immune health. Curr Opin Gastroenterol 2011;27:496-501.
49. Tursi A, Brandimarte G, Giorgetti GM, et al. Mesalazine and/or Lactobacillus casei in preventing recurrence of symptomatic uncomplicated diverticular disease of the colon: a prospective, randomized, open-label study. J Clin Gastroenterol 2006;40:312-6. (Pubitemid 44309523)
50. Annibale B, Maconi G, Lahner E, et al. Efficacy of Lactobacillus paracasei sub. paracasei F19 on abdominal symptoms in patients with symptomatic uncomplicated diverticular disease: a pilot study. Minerva Gastroenterol Dietol 2011;57:13-22.
51. Tursi A. Antibiotics and probiotics in the treatment of diverticular disease. J Clin Gastroenterol 2011;45(Suppl 1):46-52.